56 employees
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.
2009
$38M
from 3 investors over 3 rounds
Sensorion raised $38M on August 3, 2023
Investors: Redmile Group, The Invus Group and Sofinnova Partners